BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6894680)

  • 1. [The utilization of small repeated doses of iodine 131 in the treatment of Graves' disease. Results (author's transl)].
    Latapie JL; Lefort G; Commenges M; Roger P; Riviere LJ; Mauriac L
    Ann Endocrinol (Paris); 1980; 41(6):601-5. PubMed ID: 6894680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of Grave's disease by radio iodine. Observation of 277 patients (author's transl)].
    San Marco JL; Tobiana F; Dupin B; Simonin R
    Ann Endocrinol (Paris); 1980; 41(6):597-600. PubMed ID: 6894679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The treatment of Graves' disease with antithyroid drugs and small doses of radioiodine (author's transl)].
    Jafiol C; Baldet L; Papachristou C; Lavit C; Mirouze J
    Ann Endocrinol (Paris); 1980; 41(6):593-6. PubMed ID: 6166243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Long term effects of the treatment of the Graves' disease by 4 different therapeutics (author's transl)].
    Mornex R; Quintana J; Chavrier B
    Ann Endocrinol (Paris); 1977; 38(4):273-82. PubMed ID: 578399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transient hypothyroidism after iodine-131 treatment of Graves' disease.
    Gómez JM; Virgili N; Soler J; Fernández M; Montaña E
    Thyroidology; 1989 Dec; 1(3):149-52. PubMed ID: 2484879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of hypothyroidism following small doses of 131I in the treatment of Graves' disease.
    McCullagh EP; Jelden GL; Rodriguez-Antunez A
    Ohio State Med J; 1976 Sep; 72(9):538-40. PubMed ID: 989600
    [No Abstract]   [Full Text] [Related]  

  • 7. Relevance of cause of hyperthyroidism in determining its management.
    Veneman TF; Weymer M; Tjabbes T; van Haeften TW
    Neth J Med; 1989 Dec; 35(5-6):303-8. PubMed ID: 2635287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term follow-up study of radioiodine treatment of hyperthyroidism.
    Metso S; Jaatinen P; Huhtala H; Luukkaala T; Oksala H; Salmi J
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):641-8. PubMed ID: 15521969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Surgical treatment of graves' disease: is it still appropriate today? (author's transl)].
    Bürgi H; Lupi GA; Maurer W
    Ther Umsch; 1979 Oct; 36(10):899-903. PubMed ID: 93787
    [No Abstract]   [Full Text] [Related]  

  • 10. Cordocentesis to predict fetal outcome after administration of radio-active iodine for Graves' disease.
    Calderwood C; Williams H; Campbell IW; Toft AD; Cameron A
    J Obstet Gynaecol; 2002 Mar; 22(2):217-8. PubMed ID: 12521713
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prognostic evolution of Graves' disease. Surgical treatment (author's transl)].
    Putelat R; Brun JM; Ferry C; Lalloue C
    Ann Endocrinol (Paris); 1980; 41(6):606-10. PubMed ID: 6894681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A contribution to radioactive iodine therapy of the euthyroid goitre (author's transl)].
    Langenbruch K; Rische D
    Rontgenblatter; 1982 Jun; 35(6):241-4. PubMed ID: 7089436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Results of treating relapses of diffuse toxic goiter with radioactive iodine].
    Iaroslavtsev SA; Shvetsov SK
    Klin Med (Mosk); 1985 Dec; 63(12):70-3. PubMed ID: 3841571
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of adjunctive potassium iodide after radioactive iodine (131I) treatment of Graves' hyperthyroidism.
    Ross DS; Daniels GH; De Stefano P; Maloof F; Ridgway EC
    J Clin Endocrinol Metab; 1983 Aug; 57(2):250-3. PubMed ID: 6688081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relapse of Graves' disease 23 years after treatment with radioactive iodine (131I).
    Hegele RA; Volpé R
    J Clin Lab Immunol; 1985 Oct; 18(2):103-5. PubMed ID: 3841162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyrotropin receptor antibodies and Graves' disease, a side-effect of 131I treatment in patients with nontoxic goiter.
    Nygaard B; Knudsen JH; Hegedüs L; Scient AV; Hansen JE
    J Clin Endocrinol Metab; 1997 Sep; 82(9):2926-30. PubMed ID: 9284721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypothyroidism after iodine-131 or surgical therapy for Graves' disease hyperthyroidism.
    Gómez JM; Gómez N; Amat M; Biondo S; Rafecas A; Jaurrieta E; Soler J
    Ann Endocrinol (Paris); 2000 Sep; 61(3):184-91. PubMed ID: 10970941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of hyperthyroidism caused by Graves' disease or toxic multinodular goitre by radioiodine: over 80% cure retrospectively after one calculated dose].
    Bakker SC; Zanin DE; Zweers EJ
    Ned Tijdschr Geneeskd; 2002 Sep; 146(39):1837-41. PubMed ID: 12382370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term follow-up study of compensated low-dose 131I therapy for Graves' disease.
    Sridama V; McCormick M; Kaplan EL; Fauchet R; DeGroot LJ
    N Engl J Med; 1984 Aug; 311(7):426-32. PubMed ID: 6205272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A rare case of Graves' disease in a patient on regular haemodialysis].
    Boubaker K; Ounissi M; Khiari K; Harzallah A; Abbes M; El Younsi F; Ben Abdellah T; Ben Maïz H; Kaaroud H; Kheder A
    Nephrol Ther; 2010 Jul; 6(4):251-4. PubMed ID: 20488772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.